229 related articles for article (PubMed ID: 9825085)
1. Cidofovir in the treatment of cytomegaloviral disease.
Kendle JB; Fan-Havard P
Ann Pharmacother; 1998 Nov; 32(11):1181-92. PubMed ID: 9825085
[TBL] [Abstract][Full Text] [Related]
2. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS.
Plosker GL; Noble S
Drugs; 1999 Aug; 58(2):325-45. PubMed ID: 10473024
[TBL] [Abstract][Full Text] [Related]
3. Cidofovir.
Lea AP; Bryson HM
Drugs; 1996 Aug; 52(2):225-230; discussion 231. PubMed ID: 8841740
[TBL] [Abstract][Full Text] [Related]
4. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.
Lalezari JP; Holland GN; Kramer F; McKinley GF; Kemper CA; Ives DV; Nelson R; Hardy WD; Kuppermann BD; Northfelt DW; Youle M; Johnson M; Lewis RA; Weinberg DV; Simon GL; Wolitz RA; Ruby AE; Stagg RJ; Jaffe HS
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(4):339-44. PubMed ID: 9525435
[TBL] [Abstract][Full Text] [Related]
5. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
Lalezari JP; Stagg RJ; Kuppermann BD; Holland GN; Kramer F; Ives DV; Youle M; Robinson MR; Drew WL; Jaffe HS
Ann Intern Med; 1997 Feb; 126(4):257-63. PubMed ID: 9036797
[TBL] [Abstract][Full Text] [Related]
6. (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue.
Lalezari JP; Drew WL; Glutzer E; James C; Miner D; Flaherty J; Fisher PE; Cundy K; Hannigan J; Martin JC
J Infect Dis; 1995 Apr; 171(4):788-96. PubMed ID: 7706804
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation of systemic treatments for cytomegalovirus retinitis in patients with AIDS.
Lee TA; Sullivan SD; Veenstra DL; Ramsey SD; Steger PJ; Malinverni R; Pleil AM; Williamson T
Pharmacoeconomics; 2001; 19(5 Pt 2):535-50. PubMed ID: 11465299
[TBL] [Abstract][Full Text] [Related]
8. Clinical experience with cidofovir in the treatment of cytomegalovirus retinitis.
Lalezari JP; Kuppermann BD
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S27-31. PubMed ID: 9058615
[TBL] [Abstract][Full Text] [Related]
9. Cidofovir: a new therapy for cytomegalovirus retinitis.
Lalezari JP
J Acquir Immune Defic Syndr Hum Retrovirol; 1997; 14 Suppl 1():S22-6. PubMed ID: 9058614
[TBL] [Abstract][Full Text] [Related]
10. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria.
Polis MA; Spooner KM; Baird BF; Manischewitz JF; Jaffe HS; Fisher PE; Falloon J; Davey RT; Kovacs JA; Walker RE
Antimicrob Agents Chemother; 1995 Apr; 39(4):882-6. PubMed ID: 7785989
[TBL] [Abstract][Full Text] [Related]
11. Nursing considerations in the use of cidofovir for CMV retinitis in patients with AIDS: report of a roundtable meeting.
Martin MA; Kane C
J Assoc Nurses AIDS Care; 1997; 8(5):66-74. PubMed ID: 9298471
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: the HPMPC Peripheral Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
AIDS; 2000 Jul; 14(11):1571-81. PubMed ID: 10983644
[TBL] [Abstract][Full Text] [Related]
13. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. A randomized, controlled trial. Studies of Ocular complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Ann Intern Med; 1997 Feb; 126(4):264-74. PubMed ID: 9036798
[TBL] [Abstract][Full Text] [Related]
14. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir.
Cundy KC
Clin Pharmacokinet; 1999 Feb; 36(2):127-43. PubMed ID: 10092959
[TBL] [Abstract][Full Text] [Related]
15. Cidofovir (HPMPC) potent against CMV.
Posit Aware; 1995; ():5. PubMed ID: 11362567
[TBL] [Abstract][Full Text] [Related]
16. Current and experimental therapeutic options for cytomegalovirus disease.
Flaherty JF
Am J Health Syst Pharm; 1996 Apr; 53(8 Suppl 2):S4-11. PubMed ID: 8728375
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
Wolf DL; RodrÃguez CA; Mucci M; Ingrosso A; Duncan BA; Nickens DJ
J Clin Pharmacol; 2003 Jan; 43(1):43-51. PubMed ID: 12520627
[TBL] [Abstract][Full Text] [Related]
18. Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation.
Platzbecker U; Bandt D; Thiede C; Helwig A; Freiberg-Richter J; Schuler U; Plettig R; Geissler G; Rethwilm A; Ehninger G; Bornhäuser M
Transplantation; 2001 Apr; 71(7):880-5. PubMed ID: 11349720
[TBL] [Abstract][Full Text] [Related]
19. Local therapy for cytomegalovirus retinitis.
Smith CL
Ann Pharmacother; 1998 Feb; 32(2):248-55. PubMed ID: 9496411
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy for cytomegalovirus infections in pediatric patients.
Kimberlin DW
Semin Pediatr Infect Dis; 2002 Jan; 13(1):22-30. PubMed ID: 12118840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
